세계의 뉴로테크 디바이스 시장 규모 조사 및 예측 : 제품, 조건, 최종사용자 및 지역별 분석(2022-2029년)

Global Neurotech Devices Market is valued approximately USD 10.90 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.5% over the forecast period 2022-2029. The neurotech devices market refers to the industry that develops and sells devices that are used to diagnose and treat neurological disorders. These devices use various technologies to interface with the nervous system, including electrical stimulation, optogenetics, and neural prosthetics. Examples of neurotech devices include brain-computer interfaces, deep brain stimulators, neurostimulators, and neuromodulators. The major driving factor for the market are rising prevalence of neurological disorders, growing geriatric population and increasing investment in research and development. Moreover, rising technological advancements and growing demand for non-invasive and minimally invasive treatments is creating lucrative growth opportunity for the market over the forecast period 2022-2029.

There has been a significant increase in the number of people affected by neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. According to the World Health Organization, neurological disorders are responsible for 6.3% of the global disease burden. This has led to an increase in demand for innovative and effective treatments, which has driven the growth of the neurotech devices market. Along with this, rapid advancements in technology have led to the development of more sophisticated and effective neurotech devices. For example, the development of brain-computer interfaces has allowed paralyzed individuals to control prosthetic limbs using their thoughts. These technological advancement have increased the efficacy and scope of neurotech devices, leading to greater demand and growth in the market. However, the high cost of Neurotech Devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Neurotech Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the global neurotech devices market due to factors such as increasing prevalence of neurological disorders, rising investment in research and development, favorable regulatory framework, and advanced healthcare infrastructure. The United States has

the largest market in North America, accounting for the majority of the regional market share. The Asia Pacific region is expected to witness the fastest growth in the neurotech devices market due to factors such as increasing prevalence of neurological disorders, rising investment in research and development, and growing healthcare infrastructure. China, Japan, and India are the major markets in the region.

Major market players included in this report are:

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Cochlear Limited
• Stryker Corporation
• LivaNova
• Nihon Kohden Corporation
• NeuroPace
• NeuroMetrix
• BrainScope

Recent Developments in the Market:

• In January 2021, Medtronic launched its latest deep brain stimulation system, the Percept PC neurostimulator, which features brain sensing technology that can record and track brain signals for more personalized therapy.
• In October 2020, Abbott Laboratories received approval from the US FDA for its Infinity DBS system, a deep brain stimulation system for the treatment of Parkinson's disease.
• In November 2020, Boston Scientific announced positive results from a clinical trial of its Vercise Genus deep brain stimulation system for the treatment of Parkinson's disease.
• In September 2020, Cochlear Limited received approval from the US FDA for its Osia 2 bone conduction hearing implant system.
• In October 2020, Stryker Corporation completed its acquisition of Wright Medical, a medical device company that specializes in orthopedics, including neurotech devices for the treatment of foot and ankle disorders.

Global Neurotech Devices Market Report Scope:

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Conditions, End-use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Neurostimulation
• Neuroprostheses
• Neurosensing
• Neurorehabilitation Devices

By Conditions:

• Pain Management
• Cognitive Disorders
• Epilepsy
• Urinary and Fecal Incontinence
• Hearing Conditions
• Parkinson's Disease
• Depression
• Sleep Disorders
• Essential Tremor

By End-use:

• Hospitals
• Ambulatory Surgical Centers
• Homecare Facilities

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Neurotech Devices Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Neurotech Devices Market, by Product, 2019-2029 (USD Billion)
  • 1.2.3. Neurotech Devices Market, by Conditions, 2019-2029 (USD Billion)
  • 1.2.4. Neurotech Devices Market, by End-use, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Neurotech Devices Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Neurotech Devices Market Dynamics

• 3.1. Neurotech Devices Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising prevalence of neurological disorders
    • 3.1.1.2. Growing Geriatric Population
    • 3.1.1.3. Increasing investment in research and development
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost of Neurotech Devices
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising technological advancements
    • 3.1.3.2. Growing demand for non-invasive and minimally invasive treatments

Chapter 4. Global Neurotech Devices Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Neurotech Devices Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Neurotech Devices Market by Product, Performance - Potential Analysis
• 6.3. Global Neurotech Devices Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
• 6.4. Neurotech Devices Market, Sub Segment Analysis
  • 6.4.1. Neurostimulation
  • 6.4.2. Neuroprostheses
  • 6.4.3. Neurosensing
  • 6.4.4. Neurorehabilitation Devices

Chapter 7. Global Neurotech Devices Market, by Conditions

• 7.1. Market Snapshot
• 7.2. Global Neurotech Devices Market by Conditions, Performance - Potential Analysis
• 7.3. Global Neurotech Devices Market Estimates & Forecasts by Conditions 2019-2029 (USD Billion)
• 7.4. Neurotech Devices Market, Sub Segment Analysis
  • 7.4.1. Pain Management
  • 7.4.2. Cognitive Disorders
  • 7.4.3. Epilepsy
  • 7.4.4. Urinary and Fecal Incontinence
  • 7.4.5. Hearing Conditions
  • 7.4.6. Parkinson's Disease
  • 7.4.7. Depression
  • 7.4.8. Sleep Disorders
  • 7.4.9. Essential Tremor

Chapter 8. Global Neurotech Devices Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global Neurotech Devices Market by End-use, Performance - Potential Analysis
• 8.3. Global Neurotech Devices Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
• 8.4. Neurotech Devices Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Ambulatory Surgical Centers
  • 8.4.3. Homecare Facilities

Chapter 9. Global Neurotech Devices Market, Regional Analysis

• 9.1. Neurotech Devices Market, Regional Market Snapshot
• 9.2. North America Neurotech Devices Market
  • 9.2.1. U.S. Neurotech Devices Market
    • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Conditions breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End-use breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Neurotech Devices Market
• 9.3. Europe Neurotech Devices Market Snapshot
  • 9.3.1. U.K. Neurotech Devices Market
  • 9.3.2. Germany Neurotech Devices Market
  • 9.3.3. France Neurotech Devices Market
  • 9.3.4. Spain Neurotech Devices Market
  • 9.3.5. Italy Neurotech Devices Market
  • 9.3.6. Rest of Europe Neurotech Devices Market
• 9.4. Asia-Pacific Neurotech Devices Market Snapshot
  • 9.4.1. China Neurotech Devices Market
  • 9.4.2. India Neurotech Devices Market
  • 9.4.3. Japan Neurotech Devices Market
  • 9.4.4. Australia Neurotech Devices Market
  • 9.4.5. South Korea Neurotech Devices Market
  • 9.4.6. Rest of Asia Pacific Neurotech Devices Market
• 9.5. Latin America Neurotech Devices Market Snapshot
  • 9.5.1. Brazil Neurotech Devices Market
  • 9.5.2. Mexico Neurotech Devices Market
• 9.6. Rest of The World Neurotech Devices Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Medtronic
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Medtronic
  • 10.2.3. Abbott Laboratories
  • 10.2.4. Boston Scientific Corporation
  • 10.2.5. Cochlear Limited
  • 10.2.6. Stryker Corporation
  • 10.2.7. LivaNova
  • 10.2.8. Nihon Kohden Corporation
  • 10.2.9. NeuroPace
  • 10.2.10. NeuroMetrix
  • 10.2.11. BrainScope

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption